20-Sep-2022

娛樂城 receives FDA clearance for OptaBlateTM Bone Tumor Ablation System

娛樂城's first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors

Portage, Mich. 鈥 Sept. 20, 2022 鈥 娛樂城 (NYSE:SYK), one of the world鈥檚 leading medical technology companies, announced today that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug Administration. The addition of the OptaBlate technology to 娛樂城鈥檚 Interventional Spine (IVS) portfolio expands on its core competencies in vertebral augmentation and radiofrequency ablation and completes its portfolio of treatment options for metastatic vertebral body fractures.

鈥湂蕵烦氢檚 new bone tumor ablation (BTA) system is a significant improvement on existing technology and builds on 娛樂城鈥檚 IVS portfolio,鈥 said Dr. Anthony Brown, a Vascular and Interventional Radiologist at Radiology Imaging Associates, CO. 鈥淭here is no more deserving patient population for our attention and intervention; OptaBlate will change lives.鈥

As 娛樂城鈥檚 first Interventional Oncology technology, OptaBlate optimizes all aspects of the procedure鈥攆rom set-up to ablation. Featuring four probes and 娛樂城鈥檚 unique and patented microinfusion technology*, OptaBlate allows physicians to easily customize their procedure and reduce ablation time by three minutes.1

Specific key features of the system include:

  • Treatment of two vertebral body levels at once using a bipedicular approach
  • Quicker, more consistent ablation1
  • Microinfusion technology, which keeps the zone hydrated, reducing impedance errors and preventing charring1

鈥淥ur commitment to our customers and understanding their needs has never been stronger. The collaboration has helped us to develop a more efficient bone tumor ablation system to address their unmet needs,鈥 said Greg Siller, vice president and general manager of 娛樂城鈥檚 Interventional Spine business. 鈥淥ptaBlate will help our customers provide another treatment option for those suffering from painful metastatic cancer, and this is just the beginning.鈥

娛樂城鈥檚 Interventional Spine business will introduce its OptaBlate as part of its minimally invasive portfolio at the North American Spine Society Annual Meeting, Oct. 12-15, in Chicago, IL. (Booth #4211).

For questions, please .

娛樂城 娛樂城鈥檚 Interventional Spine
We are working to advance interventional care from diagnosis to delivery. For more information, visit  and connect with us on , , , and .

娛樂城 娛樂城
娛樂城 is one of the world鈥檚 leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, 娛樂城 impacts more than 100 million patients annually. More information is available at www.stryker.com.

Media contact
Jennifer Lentner
Sr. Director, Marketing Communications
jennifer.lentner@stryker.com